Seller record · medgm.org

MEDGm

Fails 3 of 8 criteria. S2, prescription gating: The order path reaches a checkout with no intake on it. The buy control on a product page opens a page headed that a prescription plan is approved, carrying a countdown on that approval and a purchase button, and the page holds no form and no medical question. 2 more criteria also fail; see the table below.

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide injections and a compounded semaglutide tablet, on four price rungs each. It names four filling pharmacies with street addresses, and its order path reaches a checkout without asking a medical question.

Operating entity MEDGm, LLC

Dispositions

CodeCriterionDispositionWhere it was read
S1Prescriber requirementPASSmedgm.org/terms
S2Prescription gatingFAILmedgm.org/glp-1/quiz
S3Pharmacy identificationPASSmedgm.org/terms
S4Compounding disclosurePASSmedgm.org/terms
S5Analytical documentationFAILmedgm.org
S6Business addressFAILmedgm.org/contact
S7Price disclosurePASSmedgm.org/products/compounded-semaglutide-injection
S8Enforcement statusPASSfda.gov

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSProviders licensed in the United States hold the prescribing decision through affiliated professional corporations, and the company states it does not practice medicine.Source: medgm.org/terms.
S2FAILThe order path reaches a checkout with no intake on it. The buy control on a product page opens a page headed that a prescription plan is approved, carrying a countdown on that approval and a purchase button, and the page holds no form and no medical question.Source: medgm.org/glp-1/quiz.
S3PASSFour filling pharmacies are named with street addresses and telephone numbers: RedRock Pharmacy, Health Warehouse, Precision Medicine and Triad Rx.Source: medgm.org/terms.
S4PASSThe terms state that compounded GLP-1 medications are not FDA-approved and have not been evaluated for safety, efficacy or quality, and name the compounding categories used.Source: medgm.org/terms.
S5FAILNo certificate, lot report or purity document is published or linked on any page read.Source: medgm.org.
S6FAILNo street address is published. The contact page gives an email address and a telephone number and nothing else, and the terms print no operating address.Source: medgm.org/contact.
S7PASSAll three products publish four priced rungs before intake, each stating both the total charged and the resulting monthly rate.Source: medgm.org/products/compounded-semaglutide-injection.
S8PASSNo FDA warning letter names this seller, and the control letter found in the same run proves the search worked. The screen covered the brand and the operating entity MEDGm, LLC across the full index.Source: fda.gov.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, compounded tirzepatide injection, compounded semaglutide tablets, brand Wegovy, Zepbound and Ozempic through a membership.

Partner link. The site earns a commission on care started through it. Funding.

Visit MEDGm

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.